In 2017, two important preclinical studies involving transient middle cerebral artery occlusion (MCAO) mouse models suggested novel roles for tau in acute ischemic injury, indicating that agents targeting tau and related proteins have the potential to reduce the severity of acute brain damage following stroke [10, 11]. Here, MAPT is linked to stroke disorder.